|
USP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.80648895421155E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.79060000160547E-09 |
| Normal-vs-Stage2 |
5.89799999950458E-08 |
| Normal-vs-Stage3 |
3.51209950011366E-10 |
| Normal-vs-Stage4 |
3.90069998523757E-09 |
| Stage1-vs-Stage2 |
2.159200E-01 |
| Stage1-vs-Stage3 |
2.062000E-01 |
| Stage1-vs-Stage4 |
2.003400E-01 |
| Stage2-vs-Stage3 |
7.699400E-01 |
| Stage2-vs-Stage4 |
9.881800E-01 |
| Stage3-vs-Stage4 |
7.660400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.28740368260583E-11 |
| Normal-vs-AfricanAmerican |
7.392900E-04 |
| Normal-vs-Asian |
1.32480000003543E-06 |
| Caucasian-vs-AfricanAmerican |
4.298800E-01 |
| Caucasian-vs-Asian |
7.417600E-01 |
| AfricanAmerican-vs-Asian |
6.282600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.74059655577707E-11 |
| Normal-vs-Female |
2.08559947090237E-10 |
| Male-vs-Female |
1.582160E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.04729999911891E-08 |
| Normal-vs-Age(41-60Yrs) |
7.65920660228403E-12 |
| Normal-vs-Age(61-80Yrs) |
2.95240054626333E-10 |
| Normal-vs-Age(81-100Yrs) |
4.276400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.128640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.453580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.372400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.719200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.692200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.233000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.559820E-01 |
| Classical-VS-Follicular |
1.399800E-04 |
| Classical-VS-Other |
1.461020E-01 |
| Classical-VS-Normal |
1.46840000159187E-08 |
| Tall-VS-Follicular |
3.373200E-01 |
| Tall-VS-Other |
4.785200E-01 |
| Tall-VS-Normal |
1.67650000004738E-06 |
| Follicular-VS-Other |
8.855400E-01 |
| Follicular-VS-Normal |
2.40569786313927E-11 |
| Other-VS-Normal |
1.177190E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.58929602390413E-11 |
| Normal-vs-N1 |
2.07229999826808E-09 |
| N0-vs-N1 |
3.163200E-01 |
|
|
